SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:0143 3334 "

Sökning: L773:0143 3334

  • Resultat 171-180 av 274
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
171.
  •  
172.
  •  
173.
  •  
174.
  •  
175.
  •  
176.
  •  
177.
  • Packer, Leisl, et al. (författare)
  • Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN
  • 2006
  • Ingår i: Carcinogenesis. - : Oxford University Press (OUP). - 0143-3334 .- 1460-2180. ; 27:9, s. 1778-1786
  • Tidskriftsartikel (refereegranskat)abstract
    • The tumor suppressor PTEN antagonizes phosphatidylinositol 3-kinase (PI3K), which contributes to tumorigenesis in many cancer types. While PTEN mutations occur in some melanomas, their precise mechanistic consequences have yet to be elucidated. We sought to identify novel downstream effectors of PI3K using a combination of genomic and functional tests. Microarray analysis of 53 melanoma cell lines identified 610 genes differentially expressed (P < 0.05) between wild-type lines and those with PTEN aberrations. Many of these genes are known to be involved in the PI3K pathway and other signaling pathways influenced by PTEN. Validation of differential gene expression by qRT-PCR was performed in the original 53 cell lines and an independent set of 18 melanoma lines with known PTEN status. Osteopontin (OPN), a secreted glycophosphoprotein that contributes to tumor progression, was more abundant at both the mRNA and protein level in PTEN mutants. The inverse correlation between OPN and PTEN expression was validated (P < 0.02) by immunohistochemistry using melanoma tissue microarrays. Finally, treatment of cell lines with the PI3K inhibitor LY294002 caused a reduction in expression of OPN. These data indicate that OPN acts downstream of PI3K in melanoma and provides insight into how PTEN loss contributes to melanoma development.
  •  
178.
  •  
179.
  • Parhamifar, Ladan, et al. (författare)
  • Activation of cPLA2 is required for leukotriene D4-induced proliferation in colon cancer cells.
  • 2005
  • Ingår i: Carcinogenesis. - : Oxford University Press (OUP). - 0143-3334 .- 1460-2180. ; 26:Jun 23, s. 1988-1998
  • Tidskriftsartikel (refereegranskat)abstract
    • It is well documented that prolonged inflammatory conditions, particularly those relating to the colon, have been shown to induce cancer. We have previously demonstrated that the pro-inflammatory mediator leukotriene D-4 (LTD4) induces survival and proliferation in intestinal cells and that its receptor, CysLT(1), is upregulated in human colon cancer tissue. Here we demonstrate, for the first time that in both Int 407 (a non-transformed human intestinal epithelial cell line) and Caco-2 cells (a human colorectal carcinoma cell line), cytosolic phospholipase A(2)alpha (cPLA(2)alpha) is activated and translocates to the nucleus upon LTD4 stimulation via a calcium-dependent mechanism that involves activation of protein kinase C (PKC), and the mitogen-activated protein kinases ERK1/2 and p38. We also show with a cPLA(2)alpha promoter luciferase assay, that LTD4 induces an increase in the transcriptional activity of cPLA(2)alpha via activation of cPLA(2)alpha and the transcription factor NF kappa B. Interestingly we demonstrate here that both the basal and the LTD4-induced cPLA(2)alpha activity is elevated similar to 3-fold in Caco-2 colon cancer cells compared with Int 407 cells. The difference in basal activity was confirmed in human colon tumor samples by the finding of a similar increase in cPLA(2)alpha activity when compared with normal colon tissue. A functional role of the increased cPLA(2)alpha activity in tumor cells was revealed by our findings that inhibition of this enzyme reduced both basal and LTD4-induced proliferation, the effects being most pronounced in Caco-2 tumor cells. The present data reveal that cPLA(2)alpha, an important intracellular signal activated by inflammatory mediators, is an important regulator of colon tumor growth.
  •  
180.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 171-180 av 274
Typ av publikation
tidskriftsartikel (269)
forskningsöversikt (5)
Typ av innehåll
refereegranskat (268)
övrigt vetenskapligt/konstnärligt (6)
Författare/redaktör
Hemminki, K (57)
Kumar, R. (16)
Riboli, Elio (13)
LAMBERT, B (13)
Burwinkel, B (12)
Boeing, Heiner (11)
visa fler...
Tumino, Rosario (11)
Stenius, U (11)
Overvad, Kim (10)
Khaw, Kay-Tee (10)
Jenab, Mazda (10)
Vineis, Paolo (10)
Trichopoulos, Dimitr ... (10)
Schmutzler, RK (10)
Hogberg, J (10)
Wappenschmidt, B. (10)
VODICKA, P (10)
Boutron-Ruault, Mari ... (9)
Trichopoulou, Antoni ... (9)
MOLLER, L (9)
Bartram, CR (9)
Kaaks, Rudolf (8)
Barricarte, Aurelio (8)
Weiderpass, Elisabet ... (8)
Canzian, Federico (8)
Meindl, A (8)
Bermejo, JL (8)
Clavel-Chapelon, Fra ... (7)
Krogh, Vittorio (7)
Panico, Salvatore (7)
Bueno-de-Mesquita, H ... (7)
Hemminki, Kari (7)
Lund, Eiliv (6)
Palli, Domenico (6)
Tjonneland, Anne (6)
Hallmans, Göran (6)
Gustafsson, JA (6)
Försti, Asta (6)
Frank, B. (6)
Peeters, Petra H (5)
Sánchez, Maria-José (5)
Eriksson, LC (5)
ZEISIG, M (5)
Duell, Eric J. (5)
Gyllensten, Ulf (5)
Amos, Christopher I. (5)
Segerback, D (5)
Rafter, JJ (5)
WIMAN, KG (5)
Zhao, CY (5)
visa färre...
Lärosäte
Karolinska Institutet (200)
Lunds universitet (41)
Umeå universitet (25)
Uppsala universitet (21)
Örebro universitet (9)
Linköpings universitet (9)
visa fler...
Stockholms universitet (6)
Göteborgs universitet (5)
Kungliga Tekniska Högskolan (5)
Chalmers tekniska högskola (4)
Mälardalens universitet (3)
Sveriges Lantbruksuniversitet (2)
Jönköping University (1)
Högskolan i Skövde (1)
visa färre...
Språk
Engelska (274)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (91)
Naturvetenskap (7)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy